.@Reuters: @SenFinance Chairman @ChuckGrassley has asked Swiss drugmaker @Novartis AG to provide details on data manipulation related to its $2 million gene therapy, Zolgensma, by Aug. 23.https://www.reuters.com/article/us-novartis-zolgensma/senator-grassley-seeks-info-on-novartiss-zolgensma-data-issues-idUSKCN1V21ZO …
-
Show this thread
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.